Overview

Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery

Status:
Withdrawn

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effect of naltrexone hydrochloride(HCL) and bupropion hydrochloride extended release combination (NB) compared with placebo on weight loss in obese participants post bariatric surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Takeda

Treatments:

Bupropion
Naltrexone